SOL Capital Management CO Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SOL Capital Management CO cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 30,884 shares of the exchange traded fund’s stock after selling 1,221 shares during the quarter. SOL Capital Management CO’s holdings in SPDR S&P Biotech ETF were worth $2,781,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of XBI. Avior Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $40,000. ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $44,000. Finally, Howe & Rusling Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $49,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $93.54 on Friday. The stock has a 50-day simple moving average of $93.31 and a two-hundred day simple moving average of $96.77. The firm has a market capitalization of $7.13 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.